[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343340-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343340-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-of-telomererelated-lncrnas-and-immunological-analysis-in-ovarian-cancer","Identification of telomererelated lncRNAs and immunological analysis in ovarian cancer","","Ovarian cancer remains a globally prevalent malignancy driven by metastatic invasion and recurrence, and practical prognostic markers are not yet fully defined. The study analyzes telomere-related long non-coding RNAs (TRLs) using TCGA mRNA and clinical data to build a six-TRL prognostic model via univariate, LASSO, and multivariate regression, with nomogram-based evaluation and external validation. Immune infiltration, TMB, and drug sensitivity are assessed, and PTPRD-AS1 knockdown experiments examine functional effects on CAOV3 cell proliferation, clonogenicity, migration, and wound healing.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-telomererelated-lncrnas-and-immunological-analysis-in-ovarian-cancer/343340/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-telomererelated-lncrnas-and-immunological-analysis-in-ovarian-cancer/343340.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data source and strategy were used to construct the telomere-related lncRNA prognostic model?","Question",{"text":63,"@type":64},"The model used relevant mRNA and clinical data for ovarian cancer sourced from the TCGA database, followed by univariate, LASSO, and multivariate regression analyses to define telomere-related lncRNA prognostic features.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which telomere-related lncRNAs make up the six-TRL prognostic model?",{"text":68,"@type":64},"The six TRLs are PTPRD-AS1, SPAG5-AS1, CHRM3-AS2, AC074286.1, FAM27E3, and AC018647.3.",{"name":70,"@type":61,"acceptedAnswer":71},"How were immune patterns and treatment sensitivity linked to the risk groups?",{"text":72,"@type":64},"The high-risk TRLs group showed comparatively higher levels of regulatory T cells and M2 macrophages, while activated CD8 T cells and monocytes were higher in the opposite direction. The low-risk group demonstrated greater sensitivity to anti-cancer drugs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343340,1790174031,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","TYPE Original Research PUBLISHED 17 September 2024 DOI 10.3389/fimmu.2024.1452946  \nOPEN ACCESS  \nEDITED BY  \nEyad Elkord,  \nXi’an Jiaotong-Liverpool University, China  \nREVIEWED BY  \nDipanjan Ghosh,  \nNational Institute of Pharmaceutical Education and Research, Kolkata, India Eleni Anastasiadou,  \nSapienza University of Rome, Italy  \n*CORRESPONDENCE Hailun Zhou  \n [apm70allen@126.com](apm70allen@126.com)[ ](apm70allen@126.com)Yijia Chen  \n [742886487@qq.com](742886487@qq.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 21 June 2024  \nACCEPTED 26 August 2024  \nPUBLISHED 17 September 2024  \nCITATION  \nXu W, Sang S, Wang J, Guo S, Zhang X, Zhou H and Chen Y (2024) Identiﬁcation of telomere-related lncRNAs and immunological analysis in ovarian cancer. Front. Immunol. 15:1452946 .  \ndoi: 10.3389/fimmu.2024.1452946  \nCOPYRIGHT  \n© 2024 Xu, Sang, Wang, Guo, Zhang, Zhou and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nIdentiﬁcation of telomererelated lncRNAs and immunological analysis in ovarian cancer  \nWeina Xu 1†, Shuliu Sang 2†, Jun Wang 1, Shanshan Guo 3, Xiao Zhang 3, Hailun Zhou 2* and Yijia Chen 3*  \n1 Department of TCM, Zhoujiadu Community Health Service of Shanghai Pudong New Area, Shanghai, China, 2 Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China,  \n3 Department of Gynecology, Longhua Hospital afﬁliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China  \nBackground: Ovarian cancer (OC) is a global malignancy characterized by metastatic invasiveness and recurrence. Long non-coding RNAs (lncRNAs) and Telomeres are closely connected with several cancers, but their potential as practical prognostic markers in OC is less well-deﬁned.  \nMethods: Relevant mRNA and clinical data for OC were sourced from The Cancer Genome Atlas (TCGA) database. The telomere-related lncRNAs (TRLs) prognostic model was established by univariate/LASSO/multivariate regression analyses. The effectiveness of the TRLs model was evaluated and measured via the nomogram. Additionally, immune inﬁltration, tumor mutational load (TMB), and drug sensitivity were evaluated. We validated the expression levels of prognostic genes. Subsequently, PTPRD-AS1 knockdown was utilized to perform the CCK8 assay, colony formation assay, transwell assay, and wound healing assay of CAOV3 cells.  \nResults: A six-TRLs prognostic model (PTPRD-AS1, SPAG5-AS1, CHRM3-AS2, AC074286.1, FAM27E3, and AC018647.3) was established, which can effectively predict patient survival rates and was successfully validated using external datasets. According to the nomogram, the model could effectively predict prognosis. Furthermore, we detected the levels of regulatory T cells and M2 macrophages were comparatively higher in the high-risk TRLs group, but the levels of activated CD8 T cells and monocytes were the opposite. Finally, the low-risk group was more sensitive to anti-cancer drugs. The mRNA levels of PTPRD-AS1, SPAG5-AS1, FAM27E3, and AC018647.3 were signiﬁcantly over-expressed in OC cell lines (SKOV3, A2780, CAOV3) in comparison to normal IOSE-80 cells. AC074286 .1 were over-expressed in A2780 and CAOV3cells and CHRM3-AS2 only in A2780 cells. PTPRD-AS1knockdown decreased the proliferation, cloning, and migration of CAOV3 cells.  \nConclusion: Our study identiﬁed potential biomarkers for the six-TRLs model related to the prognosis of OC.  \nKEYWORDS  \novarian cancer, prognosis, telomere, immune, lncRNA  ","cbCaifCKCTwR7MQV","https://ap.wps.com/l/cbCaifCKCTwR7MQV","pdf",7620618,15,"English","# Background\n# Methods\n## Data sources and model construction\n## Immune, TMB, and drug-sensitivity evaluation\n## In vitro functional validation\n# Results\n# Conclusion","[{\"question\":\"What data source and strategy were used to construct the telomere-related lncRNA prognostic model?\",\"answer\":\"The model used relevant mRNA and clinical data for ovarian cancer sourced from the TCGA database, followed by univariate, LASSO, and multivariate regression analyses to define telomere-related lncRNA prognostic features.\"},{\"question\":\"Which telomere-related lncRNAs make up the six-TRL prognostic model?\",\"answer\":\"The six TRLs are PTPRD-AS1, SPAG5-AS1, CHRM3-AS2, AC074286.1, FAM27E3, and AC018647.3.\"},{\"question\":\"How were immune patterns and treatment sensitivity linked to the risk groups?\",\"answer\":\"The high-risk TRLs group showed comparatively higher levels of regulatory T cells and M2 macrophages, while activated CD8 T cells and monocytes were higher in the opposite direction. The low-risk group demonstrated greater sensitivity to anti-cancer drugs.\"}]","Identification of telomererelated lncRNAs and immunological analysis in ovarian cancer | PDF",1790050782,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a894cb5975d1e249ef772160476c34b.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee4417a6dc9e94e74dd2c9f3e9521efd.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6ef6342c2d3461d25975aee22a07f95.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d957456bb37f8f79c24edd3955a3bb1f.webp",980,1385]